Results

Total Results: 491 records

Showing results for "start".

101. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
     December 01, 2015 - LMP tumors are programmed with the following characteristics: 1) they start to grow at the same rate … These analyses start with populations of women who are alive and have never developed breast cancer … prior to the age of the start of the simulation. … Start Age of 40 Years (vs. 50 Years)* Tables 10a and b. … Start Age of 45 Years (vs. 50 Years)* Table 11.

102. USPSTF: An Overview (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-06/USPSTF-overview-fact-sheet-2025-update.pdf
     January 01, 2025 - USPSTF: An Overview • • • USPSTF: An Overview The U.S. Preventive Services Task Force (USPSTF or Task Force) works to improve the health of people nationwide by making evidence-based recommendations on effective ways to prevent disease and prolong life. Through this work, the Task Force helps healthcare provi…

103. USPSTF: An Overview (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-06/uspstf-overview-fact-sheet-2021_updated_2025.pdf
     January 01, 2025 - USPSTF: An Overview • • • USPSTF: An Overview The U.S. Preventive Services Task Force (USPSTF or Task Force) works to improve the health of people nationwide by making evidence-based recommendations on effective ways to prevent disease and prolong life. Through this work, the Task Force helps healthcare provi…

104. Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/use-decision-models-development-evidence-based-clinical-preventive-services-recommendations
     May 01, 2019 - Use of Decision Models in the Development of Evidence-Based Clinical Preventive Services Recommendations Share to Facebook Share to X Share to WhatsApp Share to Email Print Table of Contents Abstract Introduction Rationale for Use of …

105. Final Research Plan: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/colorectal-cancer-screening
     May 16, 2019 - conducted by CISNET (Cancer Intervention and Surveillance Modeling Network), that address the age to start

106. Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6hyj7-3s6Qxs-brqhxPVxD
     June 06, 2017 - gastrointestinal andcar­ diovascular events) for various screening strategies, varying theage at which to start

107. USPSTF: An Overview (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-overview-fact-sheet-2021.pdf
     January 01, 2021 - USPSTF: An Overview • • • USPSTF: An Overview The U.S. Preventive Services Task Force (USPSTF or Task Force) works to improve the health of people nationwide by making evidence-based recommendations on effective ways to prevent disease and prolong life. Through this work, the Task Force helps healthcare provi…

108. USPSTF: An Overview (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-overview-fact-sheet-2021_0.pdf
     January 01, 2021 - USPSTF: An Overview • • • USPSTF: An Overview The U.S. Preventive Services Task Force (USPSTF or Task Force) works to improve the health of people nationwide by making evidence-based recommendations on effective ways to prevent disease and prolong life. Through this work, the Task Force helps healthcare provi…

109. Dwd2487Zxk6Uwpv2B4-Lqm (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dWD2487zXk6uwpv2B4-LQM
     January 12, 2016 - that mammography screening every two years can also be effective and recommends that the decision to start

110. Clinician Summary of USPSTF Recommendation: Prediabetes and Type 2 Diabetes (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/HFVpc3j6HjLDkFxfqrr4wG
     August 01, 2021 - Clinician Summary of USPSTF Recommendation: Prediabetes and Type 2 Diabetes 1 www.uspreventiveservicestaskforce.org Clinician Summary of USPSTF Recommendation Prediabetes and Type 2 Diabetes August 2021 The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians…

111. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/r3f2G_ReqS8tN48szHPCxt
     November 01, 2009 - cohort to capture reductions in breast cancer mortality (or life-years gained) occurring years after the start … mortality reductions for added use of mammography); 7 of these have a biennial interval, and all but 2 start … In all models, biennial screening start- ing at age 50 years and continuing through ages 74, 79, or 84 … Mortality and Life-Years Gained per 1000 Women, by Age of Screening Initiation and Cessation Model* Start

112. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - the risk for bleeding substantially and should be considered in the overall decision about whether to start … The USPSTF recommends that persons in this age and risk group start taking aspirin. … common aspirin use is for the primary prevention of CVD and whether physicians recommend it or patients start … Considerations Implementation The decision to start … both CVD risk and GI bleeding risk would be useful to clinicians and patients when deciding whether to start

113. Clinical Practice Update: Notable USPSTF 2024 FINAL Recommendations (pdf file)
     www.uspreventiveservicestaskforce.org/files/uspstf-year-in-review.pdf
     January 16, 2025 - Clinical Practice Update: Notable USPSTF 2024 FINAL Recommendations Clinical Practice Update: Notable USPSTF 2024 FINAL Recommendations The U.S. Preventive Services Task Force (USPSTF) provides evidence-based prevention guidance for 90 health conditions and diseases. Listed below are the most impactful final recom…

114. Final Research Plan: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-screening
     May 06, 2021 - digital breast tomosynthesis [3D mammography]) Screening strategy (e.g., screening interval, age to start

115. Archived: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening-january-2016
     January 11, 2016 - B Women aged 40 to 49 years The decision to start screening mammography in women prior to age … aged 40 to 49 y Women aged 50 to 74 y Women aged ≥75 y Recommendation The decision to start … The rate increases with an earlier start age or with annual mammography. 7 , 8 Even with the conservative … When to Start Screening Clinical trials, observational studies, and modeling studies all demonstrate … would be realized by starting screening at age 45. 7 , 8 Risk Factors That May Influence When to Start

116. From Topic Nomination to Clinical Practice: Making a Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/from-topic-nomination-to-clinical-practice-resources-overview.pdf
     June 01, 2021 - From Topic Nomination to Clinical Practice: Making a Task Force Recommendation From Topic Nomination to Clinical Practice: Making a Task Force Recommendation An Overview of Task Force Processes and Methods June 2021 How to Read This Presentation This presentation gives an overview of the processes and metho…

117. Jak5Cmryt E3Qkszf93Qbo (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/jaK5cMrYT_E3QkSzf93qbo
     January 01, 2015 - We also provided additional context about the age to start screening and the screening interval in response … women in their 40s reduce their risk of dying from breast cancer, and recommends that the decision to start

118. Dl4Dsze-Jdjcpgdazq Byj (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dL4dSze-jDjCPgDAzQ_Byj
     January 01, 2015 - We also provided additional context about the age to start screening and the screening interval in response … women in their 40s reduce their risk of dying from breast cancer, and recommends that the decision to start

119. Recommendation: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening
     June 09, 2020 - Screening Intervals There is little evidence about the optimal time to start asking about unhealthy … Many drug use disorders are chronic, relapsing conditions, and many persons who start treatment do not … Outcomes were assessed during the course of treatment in 11 trials (2-9 months after start of treatment … Follow-up ranged from 3 to 4 months to 12 or more months after the start of interventions. … significant effects on drug use or health, social, or legal outcomes of drug use at 3 to 6 months after the start

120. JAMA (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/UaT8AVUSVQwSduNs8TA-_e
     June 09, 2020 - Screening Intervals There is little evidence about the optimal time to start asking about unhealthy drug … Many drug use disorders are chronic, relapsing conditions, and many persons who start treatment do not … Outcomes were assessed during the course of treat- ment in 11 trials (2-9 months after start of treatment … Follow-up ranged from 3 to 4 months to 12 or more months after the start of interventions. … significant effects on drug use or health, social, or legal outcomes of drug use at 3 to 6 months after the start